FDA Approves Pharming's Immune Disorder Drug
The US Food and Drug Administration on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.
Source: medscape.com
Page 25 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharming Group Today - Breaking & Trending Today
Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 32,372.55 whil...
Source: businessinsider.com
Pharming Group (NASDAQ:PHAR) Trading Down 17.6%
Pharming Group (NASDAQ:PHAR – Get Rating)’s stock price dropped 17.6% during mid-day trading on Monday . The stock traded as low as $12.15 and last traded at $12.32. Approximately 139,714 shares were traded during mid-day trading, an increase of 576% from the average daily volume of 20,671 shares. The stock had previously closed at $14.96. […]
Source: modernreaders.com
FDA Greenlights First Drug for Rare Immunodeficiency Disease
Activated PI3K-delta syndrome may have a new standard of care
Source: medpagetoday.com
Nasdaq Edges Lower; Unity Biotechnology Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while...
Source: businessinsider.com